Evidence Hub

Neonatal hypocalcaemia due to maternal vitamin D deficiency: a preventable and underestimated condition

Madalena Ferreira, Maria Limbert, S. Deuchande, Cristina Novais

BMJ Case Reports, 2025

Abstract

Neonatal hypocalcaemia (NH) is a common metabolic disorder, particularly in preterm and high-risk infants. It may be life-threatening, with a broad spectrum of clinical manifestations, although early-onset cases can remain clinically silent. We describe a premature infant with refractory early-onset NH, secondary to severe maternal vitamin D deficiency. Despite an initial asymptomatic presentation, the infant developed persistent biochemical abnormalities requiring supplementation with calcium, magnesium and high-dose vitamin D. Maternal evaluation confirmed marked vitamin D deficiency with secondary hyperparathyroidism, highlighting the direct impact of maternal status on neonatal calcium homeostasis. This case illustrates how neonatal vitamin D levels depend almost entirely on maternal stores during pregnancy, making maternal hypovitaminosis D a key and preventable risk factor for NH. It also emphasises the underestimated prevalence of vitamin D deficiency among pregnant women worldwide, especially in vulnerable populations. Early recognition and intervention are therefore essential to prevent complications in both mother and child.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free